Enyo Pharma’s liver disease drus Vonafexor meets its phase 2a clinical study goals

August 10, 2021

Belite Bio Succeeds in Rare Eye Disease Phase 3 Trial

December 3, 2025

BioNTech receives $90 million from CEPI partnership

September 19, 2023

Must Read

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

April 25, 2026

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

April 25, 2026

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

April 25, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

Actuate Therapeutics medication increases survival chances in pancreatic cancer trial

Pfizer Stops Work on Next-Gen Drug For Cancer Patients

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Clinical

Azurity acquires Arbor Pharmaceuticals to form an integrated entity

Editor Picks

Enyo Pharma’s liver disease drus Vonafexor meets its phase 2a clinical study goals

Belite Bio Succeeds in Rare Eye Disease Phase 3 Trial

BioNTech receives $90 million from CEPI partnership

Must Read

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Hot Topics

About Us

Follow Us